The global apheresis market held a market value of US$ 3.7 Billion in 2022 and is estimated to reach US$ 7.97 Billion by the year 2031. The market is anticipated to register a CAGR of 9.12% during the forecast period.The global apheresis market held a market value of US$ 3.7 Billion in 2022 and is expected to grow at a CAGR of 9.12% from 2023 to 2031
Advances in apheresis technology, including the development of new devices and techniques, are making plasmapheresis procedures more efficient and less invasive. This is increasing patient acceptance and contributing to the growth of the market.
Growth Influencers:
Rising Prevalence of Blood DisordersHematological diseases significantly increase a person's risk of morbidity and mortality everywhere in the world. In May 2022 update by the CDC, sickle cell disease (SCD) affects roughly 100,000 Americans. About 1 in every 365 Black or African American infants experience it. The best method to save the life of a patient with a blood cell disorder is through early diagnosis and treatment. Therefore, the studied sector is anticipated to develop during the forecast period due to the rising burden of haematological incidences and expanding usage of apheresis as a therapy for haematological disorders.
Increasing Demand of Plasmapheresis
The increasing demand for plasmapheresis, a type of apheresis procedure that involves the removal, separation, and collection of plasma from the blood, is being driven by several factors. Autoimmune and neurological disorders, such as multiple sclerosis and myasthenia gravis, are increasing in prevalence, driving demand for plasmapheresis as a treatment option. As the global population ages, the incidence of age-related diseases such as Alzheimer's disease and dementia is increasing. This is contributing to the growing demand for plasmapheresis. Moreover, the plasma-derived therapies are used to treat a range of conditions, including bleeding disorders, immune deficiencies, and neurological disorders. The demand for these therapies is driving the need for plasmapheresis procedures to collect the plasma needed for their production.
Segments Overview:
The global apheresis market is segmented into product, type, procedure, technology, end user.By Product
- Apheresis Disposables
- Apheresis Devices
By Type
- Plasmapheresis
- Plateletpheresis
- Erythrocytapheresis
- Leukapheresis
- Photopheresis
- Others
By Procedure
- Automated blood collection (Donor Apheresis)
- Therapeutic Apheresis
By Technology
- Centrifugation
- Membrane Separation
- Selective Adsorption
By End User
- Hospital
- Blood Collection Center
Regional Overview
By region, the global apheresis market is divided into North America, Asia Pacific, Europe, and rest of the world. The North American market for apheresis is divided into the US, Canada, and Mexico.
Moreover, the European apheresis market is segmented into the UK, Germany, France, Italy, Spain, Poland, Russia, and rest of Europe. The North American market for apheresis held the largest market share of more than 31.5% in 2022. The Asia-Pacific market for bio-based chemicals is divided into China, India, Japan, Australia and New Zealand, South Korea, ASEAN, and rest of Asia Pacific. The Asia Pacific market is supposed to be the fastest growing with a CAGR of more than 11% over the anticipated period. Furthermore, the rest of the world region is divided into GCC, South Africa, Brazil, Argentina, and rest of Middle East and South Africa.
Competitive Landscape
The key players operating in the global apheresis market include B. Braun SE, Asahi Kasei Kuraray Medical Co., Ltd., Charles River Laboratories, Fresenius SE & Co. KGAA and Terumo Corporation, and others. The cumulative market share of top four players is around 40%. For instance, Asahi Kasei Medical purchased Bionova Scientific, LLC in June 2022, which offered biopharmaceutical companies contract process development services and GMP-compliant contract manufacturing services. By combining its current businesses in bioprocess consumables, equipment, and biosafety testing services with Bionova Scientific's biologics CDMO company, Asahi Kasei Medical hopes to offer biopharmaceutical firms even more value and greater customer satisfaction.
The global apheresis market report provides insights on the below pointers:
- Market Penetration: Provides comprehensive information on the market offered by the prominent players
- Market Development: The report offers detailed information about lucrative emerging markets and analyzes penetration across mature segments of the markets
- Market Diversification: Provides in-depth information about untapped geographies, recent developments, and investments
- Competitive Landscape Assessment: Mergers & acquisitions, certifications, product launches in the global apheresis market have been provided in this research report. In addition, the report also emphasizes the SWOT analysis of the leading players.
- Product Development & Innovation: The report provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
- Pricing Analysis: Pricing analysis of various components used in the manufacturing
- Manufacturing Cost Analysis: Cost-share of various components in apheresis, cost analysis of apheresis, unit cost analysis of apheresis
Apheresis Market Overview
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice
The global apheresis market report answers questions such as:
- What is the market size and forecast of the global apheresis market?
- What are the inhibiting factors and impact of COVID-19 on the global apheresis market during the assessment period?
- Which are the products/segments/applications/areas to invest in over the assessment period in the global apheresis market?
- What is the competitive strategic window for opportunities in the global apheresis market?
- What are the technology trends and regulatory frameworks in the global apheresis market?
- What is the market share of the leading players in the global apheresis market?
- What modes and strategic moves are considered favorable for entering the global apheresis market?
Table of Contents
Chapter 1. Research Framework
Chapter 2. Research Methodology
Chapter 4. Global Apheresis Market Overview
Chapter 5. Global Apheresis Market Analysis, By Product
Chapter 6. Global Apheresis Market Analysis, By Type
Chapter 7. Global Apheresis Market Analysis, By Procedure
Chapter 8. Global Apheresis Market Analysis, By Technology
Chapter 9. Global Apheresis Market Analysis, By End User
Chapter 10. Global Apheresis Market Analysis, By Region
Chapter 11. North America Apheresis Market Analysis
Chapter 12. Europe Apheresis Market Analysis
Chapter 13. Asia Pacific Apheresis Market Analysis
Chapter 14. Middle East and Africa Apheresis Market Analysis
Chapter 15. South America Apheresis Market Analysis
Chapter 16. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Asahi Kasei Medical Co. Ltd.
- B. Braun Melsungen AG
- Baxter International Inc.
- Cerus Corporation
- Charles River Laboratories International, Inc.
- Haemonetics Corporation
- Kaneka Corporation
- Kawasumi Laboratories Inc
- Nikkiso Co., Ltd.
- Terumo BCT, Inc
- Fresenius Kabi
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 215 |
Published | July 2023 |
Forecast Period | 2022 - 2031 |
Estimated Market Value ( USD | $ 3.7 Billion |
Forecasted Market Value ( USD | $ 7.97 Billion |
Compound Annual Growth Rate | 9.1% |
Regions Covered | Global |